Test Price
2,800 AEDโ Home Collection Available
KCNMA1 Gene Epilepsy & Paroxysmal Dyskinesia Genetic Test in UAE โ 2800 AED โ DHA Licensed
Executive Summary & Core Metrics
Executive Summary
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Next-Generation Sequencing with Sanger confirmation at DNA Labs UAE.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across all Emirates.
Clinical Guidance: Post-test telephonic result interpretation by a DHA-licensed Consultant Medical Genetics specialist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The KCNMA1 gene test utilizes next-generation sequencing to identify pathogenic variants associated with generalized epilepsy and paroxysmal dyskinesia (PNKD). Full gene coverage including deep intronic regions ensures high diagnostic yield for this rare but clinically significant genetic disorder. All positive findings are confirmed via Sanger sequencing to guarantee result accuracy.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% Sensitivity, full gene coverage including deep intronic regions | Standard epilepsy panel may miss rare KCNMA1 variants |
| Method | NGS with Sanger confirmation | Microarray or limited gene panel without confirmation |
| Turnaround | 3โ4 Weeks with transparent digital tracking | 4โ6 Weeks without digital status updates |
Physician Insight & Safety Protocols
โAs a Consultant in Medical Genetics at DNA Labs UAE, I emphasize that KCNMA1 variant interpretation must be integrated with the patientโs seizure semiology, developmental milestones, and family segregation patterns. A positive result establishes a molecular diagnosis and informs prognosis, treatment selection, and recurrence risk counseling. A negative result does not exclude other genetic or acquired causes and should prompt further neurological evaluation.โ โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
โ ๏ธ Clinical Exclusion Criteria & Safety Precautions
- Active febrile illness or systemic infection โ may compromise sample quality and patient safety.
- Known bleeding diathesis or current anticoagulant therapy โ increased phlebotomy risk.
- Patients presenting in acute status epilepticus require emergency medical intervention, not elective genetic testing.
- Sudden escalation in seizure frequency or new focal neurological deficits warrant immediate emergency department evaluation.
Do not modify or discontinue prescribed anti-epileptic medications without direct consultation with your treating neurologist.
Patient FAQ & Clinical Guidance
1. What does a positive KCNMA1 test result mean for my treatment plan?
A positive result confirms a pathogenic mutation in KCNMA1, establishing a molecular diagnosis of KCNMA1-related epilepsy-paroxysmal dyskinesia syndrome. This enables targeted therapy selection, tailored seizure management, and accurate genetic counseling for family planning. Your treating neurologist can use this information to guide medication choices and long-term prognosis.
2. Is home blood collection available for this genetic test across the UAE?
Yes. DNA Labs UAE provides VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection services in all seven Emirates, operating daily from 8 AM to 11 PM. A certified phlebotomist will visit your residence, collect a peripheral whole blood sample, and ensure its secure transport to our ISO-accredited laboratory under strict chain-of-custody protocols.
3. How is my genetic data protected under UAE law?
Your genomic data is encrypted and safeguarded under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Strict access controls, audit trails, and consent-based sharing policies ensure your genetic information remains confidential and is never disclosed without your explicit written authorization.
UAE Regulatory & Data Privacy Adherence
Comprehensive Compliance Framework
DNA Labs UAE operates under DHA Facility License Number 1143 and adheres to the highest standards of clinical data protection. All genetic testing services are conducted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. Patient consent, data encryption, and secure result delivery are embedded in every step of the diagnostic pathway.
Clinical & Logistical Metadata
| Test Name | KCNMA1 Gene Epilepsy & Paroxysmal Dyskinesia Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger Confirmation |
| ICD-10-CM Code | G40.89, G24.8 |
| LOINC Code | 51955-5 |
| DHA Facility License & Laboratory Address | License 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians